Occurrence of variants of unknown clinical significance in genetic testing for hereditary breast and ovarian cancer syndrome and Lynch syndrome: a literature review and analytical observational retrospective cohort study
Abstract Background and purpose Over the last decade, the implementation of multigene panels for hereditary tumor syndrome has increased at our institution (Inselspital, University Hospital Berne, Switzerland). The aim of this study was to determine the prevalence of variants of unknown significance...
Saved in:
Main Authors: | Felicia Adam (Author), Muriel Fluri (Author), Amina Scherz (Author), Manuela Rabaglio (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ovarian carcinoma histotype in Lynch syndrome
by: C. Blake Gilks, et al.
Published: (2017) -
How does re-classification of variants of unknown significance (VUS) impact the management of patients at risk for hereditary breast cancer?
by: Ava Kwong, et al.
Published: (2022) -
Discordant immunohistochemistry in an unusual MLH1 gene variant in a case of Lynch syndrome
by: Prerana Nagabhushana, et al.
Published: (2021) -
BRCA and lynch syndrome-associated ovarian cancers behave differently
by: Neil A.J. Ryan, et al.
Published: (2017) -
Chapter 15 Brain Tumors and the Lynch Syndrome
by: Peltomäki, Päivi
Published: (2011)